Follow Us

Menu
Log in


Log in


2025 IAP Fall cme meeting 

Meeting Points

Jump to:

Agenda

 Accreditation information  Disclosures

  Faculty Biosketches   

Download the Brochure

Register Now


Presentation slides will be available here at meeting

60670-Gavina, Kenneth

Kenneth Gavina, PhD, D(ABMM), SM(ASCP)CM

Medical Director, Clinical Microbiology and Serology, Eskenazi Health; Assistant Professor of Clinical Pathology and Laboratory Medicine IUSM


Jasan Jawanda, MD

Infectious Disease, Good Samaritan Hospital, Vincennes Indiana

Associate Program Director, Indiana University- Southwest Indiana

Internal Medicine Residency Program

44432-Lavik, John-Paul

John-Paul Lavik, MD, PhD

IUSM Assistant Professor of Clinical Pathology & Laboratory Medicine. Associate Medical Director, IU Health Division of Clinical Microbiology

Director of Medical Mycology and Parasitology Section

 

"When you hear hoofbeats, think horses zebras" - Interesting Cases in Clinical Microbiology

Objectives-Gavina

• Identify rare or atypical microbial pathogens in clinical practice and describe their distinguishing laboratory features.

• Recognize the clinical and epidemiological clues that may prompt consideration of uncommon infections.

• Evaluate and discuss real-world case studies involving diagnostic pitfalls of "zebra" infections and extract practical lessons that can be applied to routine microbiological evaluation.



Necrotizing soft tissue infections


 Objectives-Jawanda

• Recognize early clinical features that may suggest necrotizing soft tissue infections and differentiate it from other soft tissue infections

• Understand pathogenesis and microbiologic causes

• -Implement appropriate, timely management strategies, including empiric antibiotic choices and urgent surgical intervention, to reduce morbidity and mortality




Blood Parasite Diagnostics in the Real World

Objectives-Lavik

• Map the transit of a specimen through the clinical laboratory following submission for blood parasite infection testing.

• Explain (to a colleague) the medical and scientific justifications for strategies implemented in the detection, identification and characterization of parasite infections.

• Recognize that pre-analytical, analytical and post-analytical factors influence testing



Agenda

8:30 am Dr. Gavina

"When you hear hoofbeats, think horses zebras" - Interesting Cases in Clinical Microbiology

9:30 am Dr. Jawanda

Necrotizing soft tissue infections

10:30 am Break

10:50 am Dr. Lavik

Blood Parasite Diagnostics in the Real World

Return to top


CME Accreditation

Attendees will receive their CME certificate from the College of American Pathologists.

You must follow their instructions to claim credit. Approximately 4-6 weeks after the event, you will receive an email from the CAP with instructions on claiming your credit(s) hours(s) and printing your certificate.  

Gap and Needs

Presentations by experts in the field with opportunity for discussion will advance knowledge and competence of the learners

*CME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of American Pathologists and the Indiana Association of Pathologists. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians

CME Designation

The College of American Pathologists designates this live educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclaimer

The content of this accredited CE (CME) activity does not necessarily reflect the view or policies of the College of American Pathologists.

Note: While offering the CME credit hours listed in these pages, these activities are not intended to provide extensive training in a field.

Disclosure Statement**

In accordance with the ACCME Standards for Commercial Support, educational programs sponsored by the IAP must demonstrate balance, independence, objectivity and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an IAP-sponsored activity are required to disclose to attendees any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. This information will be disclosed to the learners before the presentation verbally or in printed material.

One speaker disclosed financial relationships with ineligible companies in the past 24 months.

 Speaker response to questionnaire. Diasorin products are not used in the identification of pathogens to be discussed. Roche products are not used in the identification of pathogens to be discussed. Cepheid products are not used in the identification of pathogens to be discussed. Cepheid products are not used in the identification of pathogens to be discussed.

Name of individual

Individual’s role in activity

Name of ineligible company

Nature of relationship

Mechanism(s) implemented to mitigate relevant financial relationships

Kevin Gavin, PhD

Faculty

DiaSorin Molecular

Principal investigator, consultant, speaker

Questionnaire*

Kevin Gavin, PhD

Faculty

Roche 

Principal investigator, speaker

Questionnaire*

Kevin Gavin, PhD

Faculty

Cepheid

Coyote Bioscience

Principal investigator

Questionnaire*

Kevin Gavin, PhD Faculty Bruker Principal investigator, advisor, The content was/will be peer reviewed by the entire committee and/or peer reviewers without relevant disclosures for issues.

*Speaker response to questionnaire. Diasorin products are not used in the identification of pathogens to be discussed. Roche products are not used in the identification of pathogens to be discussed. Cepheid products are not used in the identification of pathogens to be discussed. Cepheid products are not used in the identification of pathogens to be discussed

The following speakers and planners had NO financial relationships with ineligible companies in the past 24 months.

Andrew Tharp, MD

Sheila Segura, MD

Carrie Phillips, MD

Norma Erickson

Jasen Jawanda, MD

John-Paul Lavik, MD, PhD

The following In-Kind Support has been received for this activity: None

The following Commercial Support has been received for this activity: None

Back to top

Building Bridges

Physicians who are not pathologists may recognize that the learning opportunity of this seminar may help close a practice gap of their own. Non­-pathologist physicians are generally not eligible for membership with the IAP. However, we welcome these physicians and they may attend the meeting at the IAP member price. Please contact iap@indianapath.org for registration with discount.

Indiana pathologists unsure of their membership status may contact the IAP office for assistance at iap@indianapath.org.


Faculty Bios

Kenneth Gavina, PhD is Medical Director, Clinical Microbiology and Serology, Eskenazi Health; Assistant Professor of Clinical Pathology and Laboratory Medicine IUSM

More bio available soon 

Jasan Jawanda, MD's practice focuses on Infectious Disease at Good Samaritan Hospital, Vincennes Indiana. She is also the Associate Program Director, Indiana University- Southwest Indiana Internal Medicine Residency Program.

More bio available soon.

John-Paul Lavik, MD, PhD, is an associate professor of Clinical Pathology and Laboratory Medicine at Indiana University School of Medicine. He is also Associate Medical Director, IU Health Division of Clinical Microbiology and Director of Medical Mycology and Parasitology Section.


More bio available soon.

Register Now

Return to Top






Powered by Wild Apricot Membership Software